Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05967741 · ClinicalTrials.gov registry record · NA
The Effects of Dietary Erythritol on Platelet Reactivity and Vascular Inflammation
A NA study of Platelet Aggregation, Spontaneous and Vascular Thrombosis, sponsored by University of California, Davis.
- Recruiting
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT05967741: Recruiting NA study of Platelet Aggregation, Spontaneous and Vascular Thrombosis, sponsored by University of California, Davis.
NCT05967741 is a NA study of Platelet Aggregation, Spontaneous and Vascular Thrombosis that is actively recruiting participants, run by University of California, Davis. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05967741, a NA study of Platelet Aggregation, Spontaneous and Vascular Thrombosis, is actively recruiting participants, sponsored by University of California, Davis.
- RECRUITING
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose is to conduct a dietary intervention study in which human participants will consume beverages sweetened with erythritol or aspartame, each for 2 weeks, in a randomized crossover design
Primary Outcome
Change in median fluorescence intensity of P-selectin, an index of platelet activation, will be measured by flow cytometry in whole blood collected from subjects before and after consuming erythritol-sweetened beverage for 2 weeks and compared with change in whole blood collected before and after consuming aspartame-sweetened beverage for 2 weeks
Conditions Studied
Interventions
- OTHER Erythritol
- OTHER Aspartame
Study Locations (1)
California
- Ragle Human Nutrition Research Center, University of California, Davis - Davis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2023-07-20 |
| Est. Completion | 2026-06 |
| Phase | NA |
What NCT05967741 shows while recruiting
NCT05967741 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Platelet Aggregation, Spontaneous appearing as the primary indexed condition, and to 2 interventions - of which Erythritol is the first listed.
NCT05967741 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05967741 about?
NCT05967741 is a clinical study titled "The Effects of Dietary Erythritol on Platelet Reactivity and Vascular Inflammation". The purpose is to conduct a dietary intervention study in which human participants will consume beverages sweetened with erythritol or aspartame, each for 2 weeks, in a randomized crossover design
What is the current status of trial NCT05967741?
This trial is currently recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2023-07-20. Estimated completion is 2026-06.
What conditions does trial NCT05967741 study?
This clinical trial studies the following conditions: Platelet Aggregation, Spontaneous, Vascular Thrombosis.
What interventions are being tested in trial NCT05967741?
The interventions under investigation include: Erythritol (OTHER), Aspartame (OTHER).
Who is sponsoring clinical trial NCT05967741?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05967741 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Platelet Aggregation, Spontaneous
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05967741's enrollment target sits among peer trials
24 1736th of 2000 higher than 246 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI